Feem ntau cov teeb meem yog hauv zos (65%) ntawm qhov kev nthuav qhia thawj zaug thiab raug kho nrog ib nrab lossis radical nephrectomy nrog kev mob siab rau [1]. Txawm li cas los xij, relapse yog ib txwm muaj thiab tuaj yeem tshwm sim ntau xyoo tom qab pib kho [1, 3-4]. Kwv yees li tsib xyoos muaj sia nyob yog 92.6%.
Chromophobe lub raum cell carcinoma loj hlob sai npaum li cas?
Cov kws tshawb fawb pom tias 98% ntawm 95 qhov mob (81 oncocytoma, 14 chromophobe raum cell carcinoma) suav nrog hauv kev tshuaj ntsuam tau kuaj pom ntawm biopsy. Thaum lub sij hawm nruab nrab ntawm 34 thiab 25 lub hlis, feem, qhov kev loj hlob txhua xyoo yog 0.14 cm rau oncocytoma thiab 0.38 cm rau chromophobe raum cell carcinoma.
Puas yog chromophobe raum cell carcinoma kho tau?
Qhov kev cia siab ntawm chromophobe RCC zoo dua li cov pa RCC, txawm tias muaj kab mob metastatic. Nyob deb metastases muaj ntau dua nyob rau hauv daim siab thiab lub ntsws. Cov kev tshawb fawb tau ua pov thawj tias cov neeg mob chromophobe RCC muaj qhov pom zoo thiab muaj sia nyob nyob rau theem pib [20].
Pob raum mob cancer tuaj yeem rov qab los?
Qhov kev txhoj puab heev thiab feem ntau insidious ntawm lub raum cell carcinoma (RCC) yog tshwm sim los ntawm rov tshwm sim ntawm 20% mus rau 40% tom qab nephrectomy rau kev kho mob hauv zos. Anatomic staging systems raws li qog nqaij hlav, nodes, metastasis (TNM) system tau ua qhov tseem ceeb hauv RCC prognosis.
Puas RCC rov tshwm sim dua?
RCC rov tshwm sim tuaj yeemtsim nyob rau hauv cov neeg mob uas tsis tshua muaj RCC uas muaj qhov rov tshwm sim ntawm 0-7% hauv cov qog pT1 thiab 5.3-26.5% hauv pT2 cov neeg mob; Tus nqi rov qab rau Fuhrman Qib 1 cov qog yog kwv yees li 9% thiab nce mus txog 61% rau Fuhrman Qib 2 cov qog [22, 23, 24, 25, 26, 27, 28, 29].
